AI
ABBV icon

Axecap Investments’s AbbVie ABBV Stock Holding History

Axecap Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$491K Sell
1,953
-91
-4% -$19.6K 0.27% 51
2026
Q1 		$445K Sell
2,044
-14,276
-87% -$3.17M 0.31% 49
2025
Q4 		$3.73M Buy
16,320
+14,313
+713% +$3.26M 2.3% 12
2025
Q3 		$465K Sell
2,007
-25,567
-93% -$5.21M 0.29% 68
2025
Q2 		$5.12M Buy
27,574
+6,605
+31% +$1.23M 3.33% 7
2025
Q1 		$4.39M Sell
20,969
-2,870
-12% -$558K 3.72% 5
2024
Q4 		$4.24M Buy
23,839
+2,005
+9% +$369K 3.19% 6
2024
Q3 		$4.31M Buy
+21,834
New +$4.07M 3.27% 3

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Axecap Investments's ABBV Position: Q2 2026 in Review

Axecap Investments reduced its AbbVie (ABBV) stake by 4.5% in Q2 2026, selling an estimated $19.6K and leaving 1,953 shares worth $491K. The position accounts for 0.27% of the portfolio, ranked #51.

Axecap Investments first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $5.12M in Q2 2025. 4,215 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Axecap Investments held 1,953 shares of AbbVie worth $491K as of Q2 2026.
  • Axecap Investments sold 91 AbbVie shares in Q2 2026, an estimated $19.6K.
  • AbbVie made up 0.27% of Axecap Investments's portfolio in Q2 2026, its #51 holding.
  • Axecap Investments first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
  • Axecap Investments's AbbVie position peaked at $5.12M in Q2 2025.
  • 4,215 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Axecap Investments's 13F filing for Q2 2026, filed 10 Aug 2026.